ReviewNanomaterials (Basel, Switzerland)2025
Chiral Rare Earth Nanomaterials: Synthesis, Optical Properties, and Potential Applications.
Review in Nanomaterials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Chiral rare earth nanomaterials, which impart optical activity through chiral structures or ligands, possess promising application potential in optoelectronic displays, biosensing, information encryption, and catalysis due to unique properties like circularly polarized luminescence, exceptional photostability, and tunable optics. This review systematically summarizes recent advancements, focusing on synthetic strategies, distinctive optical properties, and experimental demonstrations of applications across various fields. Finally, prospects and challenges for future development are discussed. These studies advance the understanding of circularly polarized luminescence and enable the flexible design and fabrication of chiral rare earth nanomaterials with engineered functionalities, addressing practical challenges in optoelectronic displays and biomedicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.